Total cellular RNA was extracted using Trizol (Life Technologies, Gaithersburg, MD) according to the manufacturer's protocol. First-strand cDNA was synthesized from 1 mg of total cellular RNA in a 20-μL reaction volume using an RNA-PCR kit (Takara Shuzo, Kyoto, Japan) with random primers. Thereafter, cDNA was amplified for 30 or 40 cycles for MMP-9 and 28 cycles for β-actin. Oligonucleotide primers were as follows:
for MMP-9, sense, 5'-CGCAGACATCGTCATCCAGT-3' and antisense, 5'-GGATTGGCCTTGGAAGATGA-3'; and for β-actin, sense, 5'-ATCTGGCACCACACCTTCTACAATGAGCTG -3' and antisense, 5'-CGTCATACTCCTGCTTGCTGATCCACATCT -3'. Product sizes were 390 bp for MMP-2, 406 bp for MMP-9, and 838 bp for β-actin. Cycling conditions were as follows: denaturing at 95°C for 60 s for MMP-9 and 94°C for 60 s for β-actin, annealing at 62°C for 60 s for MMP-9 and 55°C for 60 s for β-actin, and extension at 72°C for 60 s for MMP-9 and β-actin. PCR products were fractionated on 2% agarose gels and visualized by ethidium bromide staining.
Western blot analysis
Cells were lysed (1% Nonidet P-40, 150mmol/l NaCl, and 0.1% sodium deoxycholate in 20 mmol/l Tris, pH 7.5) in the presence of a protease inhibitor cocktail 
Cell-conditioned media and gelatin zymography
Human T-cell lines were harvested at the exponential growth phase, washed in serum-free RPMI 1640, and cultured at a concentration of 1×10 6 cells/ml for 72 h.
CD19-positive cells of DLBCL, FL and RLH were purified by microbeads and were also cultured in FCS-free RPMI-1640. Cell-conditioned media (supernatants) were collected, concentrated 10-fold using Ultracel YM-30 (Millipore, Billerica, MA, USA)), and were analyzed by zymography according to the manufacturer's instructions (Primary Cell Co., Ltd., Ishikari, Japan)
Immunohistochemistry to detect MMP-9, CD68, and CD163 expression
Samples for histological diagnosis were formalin-fixed, paraffin-embedded and stained using the hematoxylin-eosin (H&E) method. Paraffin sections from each sample were immunostained with mouse monoclonal antibodies against MMP-9 (1:75 dilution;
Thermo Fisher Scientific, San Diego, CA), CD163 (Clone 10D6) (1:20 dilution;
Thermo Fisher Scientific), and CD68 (KP-1) (1:400 dilution; DakoCytomation, Glostrup, Denmark). CD68 and CD163 antibodies were applied and sections were incubated for 30 min at room temperature. For MMP-9 antibody, sections were treated over-night at 4°C. Biotinylated secondary antibody (10 min for CD68 and CD163, 60 min for MMP-9), followed by peroxidase-labeled streptavidin (10 min for CD68 and CD163, 30 min for MMP-9), was then applied. The period for the diaminobenzidine reaction was 4 min for CD68 and CD163, and less than 1 min for MMP-9.
Analysis of gene expression profiling
For evaluation of gene expression in DLBCL and macrophages/monocytes, previously published data sets were used (GSE11318 [1] and GSE5099 [2] ). Data were visualized by Hierarchical Clustering Explorer version 3.0 (http://www.cs.umd.edu/hcil/hce/). To calculate relative gene expression levels, gene expression levels were divided by median expression of each probe. 
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